A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.
نویسندگان
چکیده
OBJECTIVES This study was designed to determine if aspirin resistance is associated with clinical events. BACKGROUND Aspirin resistance, defined by platelet function testing and presumed clinical unresponsiveness to aspirin, has been previously reported by our group and others. However, little information exists linking the laboratory documentation of aspirin resistance and long-term clinical events. METHODS We prospectively enrolled 326 stable cardiovascular patients from 1997 to 1999 on aspirin (325 mg/day for > or =7 days) and no other antiplatelet agents. We tested for aspirin sensitivity by optical platelet aggregation using adenosine diphosphate (ADP) and arachidonic acid (AA). The primary outcome was the composite of death, myocardial infarction (MI), or cerebrovascular accident (CVA). Mean follow-up was 679 +/- 185 days. Aspirin resistance was defined as a mean aggregation of > or =70% with 10 microM ADP and > or =20% with 0.5 mg/ml AA. RESULTS Of the patients studied, 17 (5.2%) were aspirin resistant and 309 (94.8%) were not aspirin resistant. During follow-up, aspirin resistance was associated with an increased risk of death, MI, or CVA compared with patients who were aspirin sensitive (24% vs. 10%, hazard ratio [HR] 3.12, 95% confidence interval [CI] 1.10 to 8.90, p = 0.03). Stratified multivariate analyses identified platelet count, age, heart failure, and aspirin resistance to be independently associated with major adverse long-term outcomes (HR for aspirin resistance 4.14, 95% CI 1.42 to 12.06, p = 0.009). CONCLUSIONS This study demonstrates the natural history of aspirin resistance in a stable population, documenting a greater than threefold increase in the risk of major adverse events associated with aspirin resistance.
منابع مشابه
Antiplatelet Therapy A Prospective, Blinded Determination of the Natural History of Aspirin Resistance Among Stable Patients With Cardiovascular Disease
OBJECTIVES This study was designed to determine if aspirin resistance is associated with clinical events. BACKGROUND Aspirin resistance, defined by platelet function testing and presumed clinical unresponsiveness to aspirin, has been previously reported by our group and others. However, little information exists linking the laboratory documentation of aspirin resistance and long-term clinical e...
متن کاملEffect of Opium Addiction on Aspirin Resistance in Stable Angina Pectoris
Background: The rate of cardiovascular diseases in developing countries is approximately 60% and it is still has an increasing trend. The clinical effectiveness of aspirin in preventing cardiovascular events has been well proven. Although aspirin is an effective and inexpensive drug, its consumption is not equally beneficial for all patients. Many factors can be affective on the efficacy of ant...
متن کاملPrevalence of Aspirin Use among Type 2 Diabetic Patients in Iran
Abstract Objective: Patients with type 2 diabetes mellitus (DM) have a markedly increased risk of cardiovascular morbidity and mortality. There are some recommendations for prescription of aspirin in these patients. Our purpose was to determine aspirin usage rate in diabetic patients and to compare it in different ages and based upon cardiovascular disease (CVD) risk factors. Materials and M...
متن کاملEfficacy of Omega 3-6-9 fatty acids, alone or in combination with low dose aspirin, in the improvement of uterine blood flow in women with history of recurrent miscarriage: A prospective, randomized, clinical trial.
Background & Objectives: Recurrent miscarriage (RM) occurs in some women. There is much evidence that increased uterine blood flow resistance (reduced uterine perfusion) increases the risk of RM. This study was aimed at evaluating the efficacy of Omega 3-6-9 fatty acids, alone or in combination with aspirin, in the reduction of uterine blood flow resistance in women with a history of RM. Metho...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of the American College of Cardiology
دوره 41 6 شماره
صفحات -
تاریخ انتشار 2003